FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
17 letters match. Newest first.
-
BiologicsCentral Coast Multispecialty Medical Group, Inc.
FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.
High risk -
BiologicsConceive Fertility Center
FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.
High risk -
BiologicsLouisville Reproductive Center
Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.
High risk -
BiologicsGreen Valley Fertility Partners
FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.
High risk -
BiologicsInVia Fertility Specialists, PLLC
FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.
High risk -
BiologicsMG Infusions
FDA warned MG Infusions it sells unlicensed fecal transplant products online without required approval.
High risk -
BiologicsSperm Bank, Inc. dba Fertility Center of California
FDA warned Sperm Bank, Inc. dba Fertility Center of California over donor semen released without required infectious-disease testing and screening.
High risk -
BiologicsBerkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.
FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.
High risk -
BiologicsNew Mexico Lions Sight Conservation Foundation, Inc. dba New Mexico Lions Eye Bank
FDA warns New Mexico eye bank over distributing eye tissue from two donors with sepsis.
High risk -
BiologicsAkan Biosciences, Inc.
FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.
High risk -
BiologicsWashington Fertility Center
FDA warned Washington Fertility Center about incomplete donor eligibility screening and testing for oocytes, semen, and embryos.
High risk -
BiologicsHuman Microbes
FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.
High risk -
BiologicsThe New Hope Center for Reproductive Medicine
FDA warns Virginia Beach fertility center over incomplete donor screening and testing for reproductive tissue.
High risk -
BiologicsMark S. Denker, M.D., PA dba Palm Beach Fertility Center
FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.
High risk -
BiologicsCryos International USA LLC
Cryos International USA released and distributed anonymous donor semen without required infectious disease testing and quarantine.
High risk -
BiologicsSmart Surgical, Inc dba Burst Biologics
Burst Biologics distributed unapproved umbilical cord blood products as drugs while failing sterility and donor-screening rules.
High risk -
BiologicsCooper Institute
FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.
High risk